Kenvue, Inc. (KVUE)
NYSE:KVUE
KVUE Stock Chart & Stats
$17.14
-$0.04(-0.19%)
At close: 4:00 PM EST
$17.14
-$0.04(-0.19%)
Day’s Range― - ―
52-Week Range$14.02 - $25.17
Previous CloseN/A
Volume2.33M
Average Volume (3M)27.17M
Market Cap
$32.85B
Enterprise Value$40.31B
Total Cash (Recent Filing)$1.06B
Total Debt (Recent Filing)$8.52B
Price to Earnings (P/E)22.4
Beta0.04
Next Earnings
May 13, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend Yield4.85%
Share Statistics
EPS (TTM)0.27
Shares Outstanding1,916,732,000
10 Day Avg. Volume21,011,460
30 Day Avg. Volume27,171,245
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)3.06
Price to Sales (P/S)2.18
P/FCF Ratio19.14
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue2.67
Enterprise Value/Gross Profit4.59
Enterprise Value/Ebitda13.62
Forecast
1Y Price Target
$19.00Price Target Upside10.85% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.13
Revenue Forecast (FY)$15.54B
Bulls Say, Bears Say
Bulls Say
ProfitabilityGross and operating margins improved due to supply chain optimization and a favorable price and product mix, supporting stronger earnings power even as volumes softened.
Revenue GrowthOrganic sales growth exceeded expectations across all business segments, aided by favorable foreign exchange effects and reflecting resilient consumer demand in key markets.
Strategic M&AShareholder approval advanced the proposed acquisition, increasing the likelihood of completing a merger that management positions as a way to expand into higher growth consumer segments and revitalize underperforming brands.
Bears Say
Demand HeadwindsWeak consumption trends in the United States, ongoing retailer destocking, and a softer Self Care category suggest domestic sales momentum may be fragile and could weigh on near term results.
Regulatory And Deal Completion RiskPlanned acquisition remains subject to regulatory approvals outside the United States, leaving deal completion and the realization of merger benefits uncertain.
Transaction UncertaintyAbsence of forward guidance and suspended investor communications because of the pending acquisition creates uncertainty for investors assessing future performance.
Kenvue, Inc. News
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $14.02 and its highest was $25.17 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $32.85B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is May 13, 2026 which is in 39 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on Feb 17, 2026. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.05.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.207 which represents an annual dividend yield of 4.85%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.26.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,916,732,000 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.27 in its last earnings report, beating expectations of $0.22. Following the earnings report the stock price went up 2.553%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kenvue, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$19.00 (10.85% Upside)
$19.00 (10.85% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 87%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 8.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.6%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.08%
12-Months-Change
Fundamentals
Return on Equity
13.94%
Trailing 12-Months
Asset Growth
5.76%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
KVUE Revenue Breakdown
42.17% Self Care
27.20% Skin Health and Beauty
30.63% Essential Health
KVUE Stock 12 Month Forecast
Average Price Target
$19.00
▲(10.85% Upside)
Technical Analysis
Ownership Overview
1.45% Insiders
24.70% Mutual Funds
22.21% Other Institutional Investors
22.88% Public Companies and Individual Investors